ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.00
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,773.10
0.57%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) News

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:STX
DateTimeSourceHeadlineSymbolCompany
04/16/20241:00AMRNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
02/21/20246:36AMAlliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
02/21/20241:00AMRNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
01/09/20245:33AMAlliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
01/09/20241:00AMUK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
12/07/20239:31AMAlliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
12/07/20231:00AMUK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
11/27/202311:24AMUK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
10/20/20235:45AMRNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
10/12/20235:14AMAlliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
10/12/20231:00AMUK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
10/03/202311:14AMAlliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
10/03/20239:00AMUK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
10/03/20238:29AMAlliance NewsAlliance NewsShield Therapeutics completes USD20 million SWK financingLSE:STXShield Therapeutics Plc
10/03/20231:00AMUK RegulatoryShield Therapeutics PLC Completion of SWK FinancingLSE:STXShield Therapeutics Plc
10/03/20231:00AMUK RegulatoryShield Therapeutics PLC Block listing Interim ReturnLSE:STXShield Therapeutics Plc
09/28/20238:54AMAlliance NewsAlliance NewsUPDATE: Shield Therapeutics completes GBP5 million share placingLSE:STXShield Therapeutics Plc
09/28/20236:50AMUK RegulatoryShield Therapeutics PLC Successful completion of US$6.1m Equity FundraiseLSE:STXShield Therapeutics Plc
09/28/20235:30AMAlliance NewsAlliance NewsShield Therapeutics raises funds for US sales push as loss narrowsLSE:STXShield Therapeutics Plc
09/28/20231:02AMUK RegulatoryShield Therapeutics PLC REX Retail OfferLSE:STXShield Therapeutics Plc
09/28/20231:01AMUK RegulatoryShield Therapeutics PLC $20m secured debt facility &proposed equity raiseLSE:STXShield Therapeutics Plc
09/28/20231:00AMUK RegulatoryShield Therapeutics PLC Interim results update and business updateLSE:STXShield Therapeutics Plc
09/06/20232:33PMAlliance NewsAlliance NewsIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsLSE:STXShield Therapeutics Plc
09/06/20231:00AMUK RegulatoryShield Therapeutics PLC Notice of Results and Change in reporting currencyLSE:STXShield Therapeutics Plc
08/06/202311:07AMAlliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:STXShield Therapeutics Plc
08/06/20238:17AMAlliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:STXShield Therapeutics Plc
07/24/20238:27AMUK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
07/20/20235:43AMAlliance NewsAlliance NewsIN BRIEF: Shield Therapeutics prescription orders up in first quarterLSE:STXShield Therapeutics Plc
07/20/20231:00AMUK RegulatoryShield Therapeutics PLC Business Update and U.S. Q2 2023 HighlightsLSE:STXShield Therapeutics Plc
06/28/202311:30AMUK RegulatoryShield Therapeutics PLC Results of 2023 Annual General MeetingLSE:STXShield Therapeutics Plc
 Showing the most relevant articles for your search:LSE:STX

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
NYSE
AMC
AMC Entertainment
USOTC
KEGS
1812 Brewing (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
NASDAQ
AMRN
Amarin
USOTC
AABB
Asia Broadband (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
INND
Innerscope Hearing Techn... (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
SPZI
Spooz (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved